NICE and similar agencies around the world are using QALYs, hence the need for health state utility data in their assessments of the cost effectiveness of health care interventions. This raises questions about the measurement of health, the valuation of health and whose values to use. It creates additional challenges for meeting the requirements of a ‘reference case’ set of methods that may not be appropriate in all circumstances.
- What are the key issues in obtaining health state utility values?
- Does it matter which instruments are used?
- What is the current NICE reference case and requirements in other jurisdictions?
- When are EQ-5D and other generic measures not appropriate?
- What utility instruments are available for children?
- What are the latest developments in EQ-5D including EQ-5D-5L valuation?
- What should be done when EQ-5D and other generics are not appropriate or not available?
- How can mapping be used to estimate utility values from disease specific measures?
- Social value QALY weights
- How do you search for utility values and what is the role of systematic reviews and meta-analysis of utility values?
- How should utility values be incorporated into cost effectiveness models?
- What is the role for wellbeing within HTA?
- The development of condition specific measures (including the ReQol for mental health).